등록된 논문 166건

※ 클릭시 해당 논문페이지로 이동합니다.

• KCSG BR10-13유방암

  Prognostic effects of cytokine levels on patients treated with taxane and zoledronic acid for metastatic breast cancer in bone (BEAT-ZO) (KCSG BR 10-13)

  • 저널 Cytokine. 2021 Jun;142:155487.
  • 제1저자 김주원
  • 교신저자 박경화

• NA간담췌암

  Liposomal irinotecan plus fluorouracil/leucovorin versus FOLFIRINOX as the second-line chemotherapy for patients with metastatic pancreatic cancer: a multicenter retrospective study of the Korean Cancer Study Group (KCSG)

  • 저널 ESMO Open. 2021 Apr;6(2):100049.
  • 제1저자 박형순, 강버들
  • 교신저자 유창훈, 최혜진

• KCSG PC13-09완화의료

  Prevalence and Predictive Factors for Upfront Dose Reduction of the First Cycle of First-Line Chemotherapy in Older Adults with Metastatic Solid Cancer: Korean Cancer Study Group (KCSG) Multicenter Study

  • 저널 Cancers (Basel). 2021 Jan 18;13(2):331.
  • 제1저자 황인규, 권민석
  • 교신저자 우인숙

• KCSG HN18-12두경부식도암

  Outcomes and Biomarkers of Immune Checkpoint Inhibitor Therapy in Patients with Refractory Head and Neck Squamous Cell Carcinoma: KCSG HN18-12

  • 저널 Cancer Res Treat. 2021 Jul;53(3):671-677.
  • 제1저자 이윤규, 장현
  • 교신저자 안명주, 황인규

• KCSG LU16-07폐암

  Phase II study of durvalumab and tremelimumab in pulmonary sarcomatoid carcinoma: KCSG-LU16-07

  • 저널 Thorac Cancer. 2020 Dec; 11(12): 3482-3489.
  • 제1저자 김미소
  • 교신저자 김범석

• KCSG BR15-10유방암

  Implications of Tamoxifen Resistance in Palbociclib Efficacy for Patients with Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Subgroup Analyses of KCSG-BR15-10 (YoungPEARL)

  • 저널 Cancer Res Treat. 2021 Jul;53(3):695-702.
  • 제1저자 이지윤
  • 교신저자 박연희

• KCSG HN18-12두경부식도암

  Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer
  study group HN 18-12

  • 저널 J Cancer Res Clin Oncol. 2020 Dec;146(12):3359-3369
  • 제1저자 박지현, 전상훈
  • 교신저자 김성배, 김범석

• KCSG HN12-12두경부식도암

  Mouse-human co-clinical trials demonstrate superior anti-tumour effects of buparlisib (BKM120) and cetuximab combination in squamous cell carcinoma of head and neck

  • 저널 Br J Cancer. 2020 Dec;123(12):1720-1729.
  • 제1저자 김혜련, 강한나
  • 교신저자 김태민, 조병철

• KCSG HN14-18두경부식도암

  Phase 2 study of afatinib among patients with recurrent and/or metastatic esophageal squamous cell carcinoma

  • 저널 Cancer. 2020 Oct 15;126(20):4521-4531
  • 제1저자 홍민희
  • 교신저자 김태민, 김혜련, 조병철

• KCSG BR15-10유방암

  Patient-Reported Outcomes of Palbociclib Plus Exemestane with GnRH Agonist versus Capecitabine
  in Premenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer: A Prospective, Open-Label, Randomized Phase ll Trial (KCSG-BR 15-10)

  • 저널 Cancers (Basel) . 2020 Nov 5;12(11):3265.
  • 제1저자 이수현
  • 교신저자 박연희

678910